Recent news on Viokase

Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record ...  -  May 10, 2007
SYS-CON Media,Axcan is also progressing toward the completion of the NDA for VIOKASE, the only branded uncoated pancreatic enzyme formulation available in the United

Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue ...  -  Feb 8, 2007
Genetic Engineering News (press release),Axcan is currently advancing the completion of the New Drug Application ("NDA") of ULTRASE and VIOKASE, and is on track to meet the deadline for NDA

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE,

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE,

Axcan Announces Strong Third Quarter 2006 Revenue of $76.7 Million ...  Aug 10, 2006
In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs, which include VIOKASE and ULTRASE, must receive ... -Market Wire



Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
ULTRASE-VIOKASE In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs must receive approval before April ... - Canada NewsWire

Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
...products. Axcan has completed a Phase III study of VIOKASE that will serve as the basis of the New Drug Application. Additional ... - Yahoo! News





Axcan announces record revenue of $70.6 million for the first ...  Feb 9, 2006
...marketed products. Axcan has completed a Phase III study of VIOKASE that will serve as the basis of the New Drug Application. The ... - Yahoo! News

Axcan announces record revenue of $70.6 million for the first ...  09 Feb 2006
ULTRASE-VIOKASE In April 2004, the Food and Drug Administration formally notified manufacturers of pancreatic insufficiency products that these drugs must ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional